Skip to main content
Premium Trial:

Request an Annual Quote

Active Motif Acquires SwitchGear Genomics

NEW YORK (GenomeWeb News) – Active Motif announced Thursday that it has acquired privately held genomics tools maker SwitchGear Genomics for an undisclosed price.

SwitchGear was founded by a group of Stanford University scientists in 2006 and is based in Menlo Park, Calif. It developed the LightSwitch Reporter Assay System, which includes over 30,000 endogenous 3' UTR and promoter luciferase reporters, validated biomarkers, miRNA target validation sets, synthetic response elements, and optimized luciferase assay reagents to study gene regulation in living cells.

Carlsbad, Calif.-based Active Motif develops epigenetics-based research tools for analyzing nuclear function.

"There is a strong scientific connection between epigenetics and gene regulation, and the combination of our technologies will create some very exciting possibilities for our customers," Active Motif CEO Joe Fernandez said in a statement. He added that SwitchGear "has a unique combination of expertise in computational regulatory element identification, experimental validation, and data analysis that offers the scientist new and innovative high-throughput tools for studying regulatory element function across the genome."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more